Product Information

OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0611 per EA under NDC 68462043690. Its NADAC has been published 200 times since Jan 18, 2023.

FDA first approved this application on May 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 5 MG TAB

Olmesartan Medoxomil
$0.0611per EA

Strength

5 mg/1

NDC

68462043690

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA203281

FDA Approved

5/25/2017

TE Code

AB

On Market Since

5/25/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 200 times since Jan 18, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0611 per EA
All-time high$0.0844 (Sep 11, 2024)
All-time low$0.0551 (Aug 19, 2026)
52-week high$0.0611
52-week low$0.0551
Median price$0.0624
Average price$0.0634
Largest weekly change-24.8% (Nov 20, 2024)
Weeks tracked200
Tracking sinceJan 18, 2023

Price History

1W

0.0%

1M

+6.3%

3M

+9.3%

6M

+6.7%

1Y

+6.7%

3Y

-6.6%

5Y

N/A

All

-0.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0611 per EA (NDC 68462043690), effective Nov 11, 2026.

How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has held within roughly two percent of its current level. It has been tracked across 200 weekly CMS publications since Jan 18, 2023.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?

Since Jan 18, 2023, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0844 (Sep 11, 2024), with a median of $0.0624 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?

OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 68462043690) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.